Project Grant H8E38695

This $251,493 Project Grant, awarded by the National Science Foundation's Engineering program (CFDA 47.041), supports collaborative research by the University of Virginia to develop optimized pooled testing strategies for efficient COVID-19 prevalence tracking and accurate virus diagnostic testing. The key objectives are to: Design effective sampling and testing algorithms to estimate community prevalence under scarce testing resource constraints. Develop optimized pooling and decoding...

Numentus Technologies Inc. received a $303,685 Project Grant award from the National Science Foundation on February 15, 2021 to develop rapid planar PCR technology for COVID-19 testing. The award was made under the NSF's Engineering program (CFDA 47.041) to support innovation and excellence in engineering research. Through this funding, Numentus will work to advance the development of planar PCR, a technology that enables highly sensitive COVID-19 detection on a single integrated testing...

The Centers for Disease Control and Prevention (CDC) awarded the State of Wisconsin Department of Health Services a $3,361,552 Cooperative Agreement under the Strengthening Public Health Systems and Services through National Partnerships to Improve and Protect the Nation's Health (CFDA 93.421) program. The funding supports a 5-year project from August 1, 2024 to July 31, 2029 to enhance the state's capacity for epidemiologic surveillance, laboratory testing, public health informatics, and...

This Cooperative Agreement award of $1,496,617 from the Centers for Disease Control and Prevention (CDC), under the Tribal Public Health Capacity Building and Quality Improvement Umbrella Cooperative Agreement (CFDA 93.772) program, supports a project by the Wyoming Department of Health to bolster the state's epidemiology, laboratory, and health information systems capacity for preventing and controlling emerging infectious diseases. The key products and services to be delivered include:...

This $968,765 Project Grant awarded by the National Science Foundation's (NSF) Division of Mathematical Sciences (CFDA 47.049 - Mathematical and Physical Sciences) will develop a flexible modeling framework to simulate the impact of various testing-based infection control strategies for respiratory pathogens like SARS-CoV-2. The project aims to improve our ability to control existing respiratory diseases and enhance preparedness for future pandemics. Key deliverables include: Developing a...

The Tennessee Department of Health was awarded a $1,822,620.00 Cooperative Agreement by the Centers for Disease Control and Prevention's (CDC) Epidemiology and Laboratory Capacity for Infectious Diseases (ELC) program on August 1, 2024. The five-year award will enhance the state's public health infrastructure and capacity to address emergent situations, capacity deficits, programmatic gaps, and unanticipated events. Key initiatives include expanding syringe service programs to combat Hepatitis...

This Cooperative Agreement award from the Centers for Disease Control and Prevention (CDC) under the Epidemiology and Laboratory Capacity for Infectious Diseases (CFDA 93.323) program provides $2,254,030.00 to the Ohio Department of Health (ODH) to build and strengthen epidemiology, laboratory, and health information systems to detect, respond, prevent, and control known and emerging infectious diseases in Ohio. The award will enable ODH to work with 111 local health departments across the...

This $960,000 National Science Foundation project grant supports the development of a multiplexed plasmon-enhanced lateral flow assay for point-of-care detection of SARS-CoV-2 RNA and antigens. Funded under the NSF Engineering program (CFDA 47.041), the grantee, Washington University, will design, validate and build a novel diagnostic platform with sensitivity exceeding standard laboratory tests. Key deliverables include an ultrasensitive multiplexed lateral flow assay for simultaneous...

The National Science Foundation awarded a $220,000 Project Grant to the University of Connecticut under the Engineering (47.041) federal grant program. The award will fund development of a compact, field-portable biophotonics instrument for automated analysis and identification of blood cells impacted by COVID-19. The instrument aims to provide real-time sensing and diagnosis capabilities with high accuracy, specificity and sensitivity for potential early detection of COVID-19 infections. It...

This federal Cooperative Agreement award, provided by the Centers for Disease Control and Prevention (CDC) under the Epidemiology and Laboratory Capacity for Infectious Diseases (ELC) program (CFDA 93.323), is valued at $2,518,468 and will run from August 1, 2024 to July 31, 2029. The purpose of the ELC program is to enhance public health infrastructure for detecting, responding to, preventing, and controlling infectious diseases through strengthening epidemiological surveillance, laboratory...